Regulus Therapeutics
RGLS
#6949
Rank
C$0.78 B
Marketcap
C$11.39
Share price
0.00%
Change (1 day)
434.48%
Change (1 year)

Regulus Therapeutics (RGLS) - Total liabilities

Total liabilities on the balance sheet as of March 2025 : C$8.09 Million

According to Regulus Therapeutics's latest financial reports the company's total liabilities are C$8.09 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Regulus Therapeutics - Total liabilities on balance sheet (from 2011 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31C$11.15 M-12.06%
2023-12-31C$12.68 M-30.37%
2022-12-31C$18.21 M5.91%
2021-12-31C$17.19 M16.51%
2020-12-31C$14.76 M-48.78%
2019-12-31C$28.81 M-37.37%
2018-12-31C$46.01 M-14.07%
2017-12-31C$53.55 M-10.63%
2016-12-31C$59.91 M154%
2015-12-31C$23.58 M-48.49%
2014-12-31C$45.79 M45.31%
2013-12-31C$31.51 M-23.49%
2012-12-31C$41.19 M-52%
2011-12-31C$85.82 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
GlaxoSmithKline
GSK
C$85.55 B 1,056,892.07%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
C$92.17 B 1,138,690.96%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
C$15.35 B 189,620.59%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$95.60 B 1,181,083.17%๐Ÿ‡ฌ๐Ÿ‡ง UK
Alnylam Pharmaceuticals
ALNY
C$6.44 B 79,544.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
C$0.11 B 1,321.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$109.28 B 1,350,175.96%๐Ÿ‡บ๐Ÿ‡ธ USA